Last updated on November 2017


Brief description of study


Detailed Study Description

A 52 week double-blind, placedbo controlled study to evaluate the effect of roflumilast on the exacerbation rate in patients with COPD.

Clinical Study Identifier: TX81215

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )